You are here

New Guidelines for Managing Hypothyroid Disease

Focus is on inappropriate thyroid hormone administration (Sept. 12)

Mary Ann Liebert, Inc., publishers, announced on September 12 that new evidence-based guidelines for the diagnosis and treatment of hypothyroidism — a complex disease caused by an underactive thyroid gland that cannot produce enough thyroid hormone — have been published in Thyroid.

The guidelines were developed jointly by the American Thyroid Association (ATA) and the American Association of Clinical Endocrinologists (AACE).

A task force representing the ATA and AACE reviewed the medical literature and current standards of care and developed updated recommendations, which are presented in the article by lead author Jeffrey R. Garber, MD.

“The guidelines address a wide-ranging number of issues that clinicians encounter in treating a disorder that affects millions of men worldwide and an even far greater number of women,” said Charles H. Emerson, MD, Editor-in-Chief of Thyroid. “They deal firmly with the problem of inappropriate thyroid hormone administration, both as it concerns individuals who should not be taking thyroid hormone, and patients with hypothyroidism who are given or self-administer suboptimal doses or dangerous formulations for their condition.”

For more information, visit the Mary Ann Liebert, Inc. Web site.

Recent Headlines

Despite older, sicker patients, mortality rate fell by a third in 10 years
Study finds fewer than half of trials followed the law
WHO to meet tomorrow to decide on international public heath emergency declaration
Study of posted prices finds wild variations and missing data
Potential contamination could lead to supply chain disruptions
Delayed surgery reduces benefits; premature surgery raises risks
Mortality nearly doubled when patients stopped using their drugs
Acasti reports disappointing results for a second Omega-3-based drug
Declining lung cancer mortality helped fuel the progress